Tatva Chintan Pharma IPO Reviews, Dates, Price Band, Market Lot & Financial Details 2021

The Tatva Chintan Pharma IPO will hit the market soon, and you can apply for the IPO from 16th July to 20th July 2021. Tatva Chintan Pharma is planning to raise ₹500 Crores through an IPO which consists of a fresh issue of ₹225 crores worth equity and OFS (Offer For Sale) of ₹275 crores by existing shareholders.

Tatva Chintan Pharma was incorporated in 1996 at Gujrat. They manufacture phase transfer catalysts (PTCs), electrolytic and pyridinium salts, pharmaceutical and agrochemical intermediates, and structure-directing agents (SDAs). Tatva Chintan Pharma manufactures SDAs for zeolites in India and is one of its largest manufacturers.

Their products are used in industries like petroleum, paints and coatings, dyes and pigments, agrochemicals, and automobiles. Other than India, they export to more than 20 countries, including Japan, China, the United States, and the United Kingdom. Exports account for 75% of a company’s revenue. Many IPOs are going to launch this year check here the list.

Tatva Chintan Pharma IPO Dates & Price Band:

Open date16th July 2021
Close date20th July 2021
Total Size of IPO₹500 Cr.
Fresh Issue 225 Cr.
Offer for Sale₹275 Cr.
Price Band₹1073 – 1083
Face Value₹10 per share
Listing onNSE and BSE
Retail Investor’s Portion35%

Tatva Chintan Pharma IPO Market Lot:

The minimum market lot of Tatva Chintan Pharma IPO is 13 shares with 14,820 applications. Retail investors can apply for 14 lots with 182 shares application worth 197,106.

ApplicationLotSharesCut Off Amount
Minimum (RII)11314,820
Maximum (NII)14182197,106

Objectives of Issue – 

  • To fund the expenditure requirements for expansion of the Dahej manufacturing facility.
  • To fund the up-gradation of R&D facilities at Vadodra.
  • To meet general corporate purposes.

Should you subscribe to Tatva Chintan Pharma IPO?

We have researched and mentioned the strengths and risks of the Tatva Chintan Pharma IPO. The final verdict will help you make the right decision.

Strength – 

  • Leading manufacturers of phase transfer catalysts (PTCs) and structure directing agents (SDAs).
  • Global presence with customer base of various industries.
  • Manufacturing plants strategically located near the Hazira port.
  • Promoters with extensive experience in the speciality chemicals manufacturing industry.
  • Company has a good financial history.

Risks – 

  • Increase in cost of raw materials can cause a huge impact on their operating profits. 
  • Failure to meet the standard norms of Indian Government or International Government can be a major risk to their products.

Final Verdict – 

Leadership in SDAs and PTCs help them maintain a strong market position. The client portfolio is well diversified in various industries like automotive, paints, petroleum, etc. The company has strong export connections in the international market, which helps them grow their business. This all contributes to the company’s success, thus giving investors a lot of confidence to invest in the Tatva Chintan Pharma IPO.

Investors can invest for the long term in the Tatva Chintan Pharma IPO. It’s early to predict but Tatva Chintan Pharma IPO can give great listing gains by seeing its grey market premium. You can keep a track of Tatva Chintan Pharma IPO GMP here.

Tatva Chintan Pharma IPO Allotment & Listing Dates:

Tatva Chintan Pharma IPO’s open date is 16th July and the closing date is 20th July. Allotment of shares will be done on 26th July and the listing date on NSE & BSE is 29th July 2021.

Allotment Date for Tatva Chintan Pharma- 26th June 2021
Refund Date for Tatva Chintan Pharma – 27th July 2021
Credit of Shares to Demat Account – 28th July 2021
Listing Date for Tatva Chintan Pharma – 29th July 2021

Applying IPO through the form: 

Besides applying IPOs through ASBA application or through Demat accounts you can also apply to IPOs with the help of forms provided by NSE or BSE. This is one of the traditional and safe ways to apply for an IPO subscription. Download the form through this link and fill the form carefully. You have to submit your filled form to the bank or broker.

Financials of Tatva Chintan Pharma IPO:

The financials of Tatva Chintan Pharma are very attractive. From 2019 the revenue numbers are increasing constantly. Net income is also increasing slightly. Upcoming financial numbers are expected to be good so we suggest investors apply for the IPO.

YearRevenue (₹ in Cr.)Expense (₹ in Cr.)PAT Net Income (₹ in Cr.)
201918713721
2020 24926537.01
2021 27619431.12

About Tatva Chintan Pharma:

Tatva Chintan Pharma Chem Pvt. Ltd. was established in Ankleshwar in 1996. They are leading manufacturers of SDAs for zeolite in India. In addition to this, they are global producers of various ranges of PTCs. There SDA and PTC have various applications in green chemistry, which initiates the go green motive. 

They are constantly searching for new solutions to ensure the safety of the environment while also delivering to their client’s expectations. One of the green chemistry processes they have undertaken is electrolysis. Tatva Chintan Pharma serves various industries like automotive, paints and coatings, agrochemical, pharmaceutical, personal care, and fragrance.

Shekhar Somani, Chintan Shah, and Ajay Patel are the promoters of Tatva Chintan Pharma. Promoters have deep knowledge and immense experience in the manufacturing of specialty chemicals. Promoter’s experience helps the team manage operations and grow their business effectively. As a result, the company has a competitive advantage over its peers.

Client Portfolio – 

They work with well-known brands in specific industries, and the list goes on like Lauras Labs, Otsuka Chemicals, Atul Ltd., SRF Ltd., Hawks Chemicals, Divi’s Laboratories, Merck, Ipox Chemicals, Bayer AG, Navin Fluorine International Limited, and Firmenich Aromatics Pvt. Ltd.

Competitor’s Comparison –

Sr.No.Company NamePE 
1Aarti Industries Ltd.41.8
2Alkyl Amines chemicals Ltd.59.29
3Vinati Organics Limited43.78
4Fine Organic Industries Limited41.35
5Navin Fluorine International Limited30.12

IPO Registrar Details –

Link Intime India Private Limited
C 101, 247 ParkL.B.S.Marg
Vikhroli (West) Mumbai 400 083
Tel: +91 22 49186200
E-mail: [email protected]
Website: www.linkintime.co.in

Tatva Chintan Pharma Contact Details –

Tatva Chintan Pharma Chem Limited
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat – 393002, India
Phone: +91 75730 46951
Email: [email protected]
Website: http://www.tatvachintan.com/

Tatva Chintan Pharma IPO FAQ –


When will Tatva Chintan Pharma IPO open for Investors?

Tatva Chintan Pharma IPO will open on 16th July 2021 and will close on 20th July 2021.

What is Tatva Chintan Pharma IPO Retail Portion?

The portion allocated for retail investors in Tatva Chintan Pharma IPO is 35%

How to apply for Tatva Chintan Pharma IPO?

You can apply Tatva Chintan Pharma IPO in 3 ways:
Open a Demat account through a bank or brokerage firm and apply through it.
Apply via ASBA application online through your bank.
Fill up the offline IPO form and submit it to the bank or broker.

Should I invest in Tatva Chintan Pharma IPO?

Leadership in SDAs and PTCs help them maintain a strong market position. The client portfolio is well diversified in various industries like automotive, paints, petroleum, etc. The company has strong export connections in the international market, which helps them grow their business. This all contributes to the company’s success, thus giving investors a lot of confidence to invest in the Tatva Chintan Pharma IPO.

What is the allotment date for Tatva Chintan Pharma shares?

26th July 2021 is the allotment date for Tatva Chintan Pharma shares.

What is the listing date for Tatva Chintan Pharma IPO?

29th July 2021 is the listing date for Tatva Chintan Pharma. It will be listed on NSE and BSE.

What is the cutoff price for Tatva Chintan Pharma IPO?

The cutoff price for Tatva Chintan Pharma IPO is ₹1083 per share.

Will Tatva Chintan Pharma IPO give listing gains?

Investors can invest for the long term in Tatva Chintan Pharma. It’s early to predict but Tatva Chintan Pharma can give great listing gains by seeing its grey market premium. You can keep a track of Tatva Chintan Pharma IPO GMP here. 


Disclaimer for Investors:

  • We on ipogmp.in do not buy or sell any kind of IPO forms.  
  • Do not subscribe to IPO just by seeing its GMP. You should do proper research about the fundamentals of a company.
  • IPO GMP changes every day and you can view the changes in the above table.
  • Always apply to an IPO after understanding financials and discussing with your financial advisor.
Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *

close